Ausgabe 3/2015
Inhalt (27 Artikel)
Targeting 12-lipoxygenase as a novel strategy to combat the effects of inflammation on beta cells in diabetes
Jan A. Ehses, Marc Y. Donath
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L. Peters, Apostolos Tsapas, Richard Wender, David R. Matthews
Epigenetic mechanisms in diabetic complications and metabolic memory
Marpadga A. Reddy, Erli Zhang, Rama Natarajan
Role of islet microRNAs in diabetes: which model for which question?
Claudiane Guay, Romano Regazzi
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
Kwok-Leung Ong, Andrzej S. Januszewski, Rachel O’Connell, Alicia J. Jenkins, Aimin Xu, David R. Sullivan, Philip J. Barter, Wei-Ting Hung, Russell S. Scott, Marja-Riitta Taskinen, Anthony C. Keech, Kerry-Anne Rye
Birthweight and risk markers for type 2 diabetes and cardiovascular disease in childhood: the Child Heart and Health Study in England (CHASE)
Claire M. Nightingale, Alicja R. Rudnicka, Christopher G. Owen, Sian L. Newton, Jennifer L. Bales, Angela S. Donin, Cathy M. McKay, Phillip J. Steer, Debbie A. Lawlor, Naveed Sattar, Derek G. Cook, Peter H. Whincup
Dose–response relationships between sedentary behaviour and the metabolic syndrome and its components
Keith P. Gennuso, Ronald E. Gangnon, Keith M. Thraen-Borowski, Lisa H. Colbert
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
Daniel Levin, Samira Bell, Reijo Sund, Sirpa A. Hartikainen, Jaakko Tuomilehto, Eero Pukkala, Ilmo Keskimäki, Ellena Badrick, Andrew G. Renehan, Iain E. Buchan, Samantha L. Bowker, Jasjeet K. Minhas-Sandhu, Zafar Zafari, Carlo Marra, Jeffrey A. Johnson, Bruno H. Stricker, Andrè G. Uitterlinden, Albert Hofman, Rikje Ruiter, Catherine E. de Keyser, Thomas M. MacDonald, Sarah H. Wild, Paul M. McKeigue, Helen M. Colhoun
Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study
Evangelos Kontopantelis, David A. Springate, David Reeves, Darren M. Ashcroft, Martin Rutter, Iain Buchan, Tim Doran
ABO and Rhesus blood groups and risk of type 2 diabetes: evidence from the large E3N cohort study
Guy Fagherazzi, Gaëlle Gusto, Françoise Clavel-Chapelon, Beverley Balkau, Fabrice Bonnet
Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study
Linéa Bonfils, Christina Ellervik, Nele Friedrich, Allan Linneberg, Camilla H. Sandholt, Marit E. Jørgensen, Torben Jørgensen, Torben Hansen, Oluf Pedersen, Kristine H. Allin
Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study
Satoyo Ikehara, Adam G. Tabák, Tasnime N. Akbaraly, Adam Hulmán, Mika Kivimäki, Nita G. Forouhi, Hiroyasu Iso, Eric J. Brunner
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes
Marine Germain, Marcus G. Pezzolesi, Niina Sandholm, Amy J. McKnight, Katalin Susztak, Maria Lajer, Carol Forsblom, Michel Marre, Hans-Henrik Parving, Peter Rossing, Iiro Toppila, Jan Skupien, Ronan Roussel, Yi-An Ko, Nora Ledo, Lasse Folkersen, Mete Civelek, Alexander P. Maxwell, David-Alexandre Tregouet, Per-Henrik Groop, Lise Tarnow, Samy Hadjadj
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction
David A. Taylor-Fishwick, Jessica Weaver, Lindsey Glenn, Norine Kuhn, Ganesha Rai, Ajit Jadhav, Anton Simeonov, Angela Dudda, Dieter Schmoll, Theodore R. Holman, David J. Maloney, Jerry L. Nadler
Ins1 Cre knock-in mice for beta cell-specific gene recombination
Bernard Thorens, David Tarussio, Miguel Angel Maestro, Meritxell Rovira, Eija Heikkilä, Jorge Ferrer
MafA is critical for maintenance of the mature beta cell phenotype in mice
Wataru Nishimura, Satoru Takahashi, Kazuki Yasuda
IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice
Clara Y. Westwell-Roper, Cyrus A. Chehroudi, Heather C. Denroche, Jaques A. Courtade, Jan A. Ehses, C. Bruce Verchere
Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance
Mark J. W. Hanssen, Roel Wierts, Joris Hoeks, Anne Gemmink, Boudewijn Brans, Felix M. Mottaghy, Patrick Schrauwen, Wouter D. van Marken Lichtenbelt
Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes
Stephanie T. Chung, Daniel S. Hsia, Shaji K. Chacko, Luisa M. Rodriguez, Morey W. Haymond
GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
Robert W. Schwenk, Christian Baumeier, Brian Finan, Oliver Kluth, Christine Brauer, Hans-Georg Joost, Richard D. DiMarchi, Matthias H. Tschöp, Annette Schürmann
Pre-gestational vs gestational exposure to maternal obesity differentially programs the offspring in mice
Isaac E. Sasson, Alexa P. Vitins, Monica A. Mainigi, Kelle H. Moley, Rebecca A. Simmons
Autophagy in the posterior interosseous nerve of patients with type 1 and type 2 diabetes mellitus: an ultrastructural study
Ayman A. M. Osman, Lars B. Dahlin, Niels O. B. Thomsen, Simin Mohseni
Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism
Kang I. Ko, Leila S. Coimbra, Chen Tian, Jazia Alblowi, Rayyan A. Kayal, Thomas A. Einhorn, Louis C. Gerstenfeld, Robert J. Pignolo, Dana T. Graves
Erratum to: ‘Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice’ and ‘Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway’
C. Zhang, C. McFarlane, S. Lokireddy, S. Bonala, X. Ge, S. Masuda, P. D. Gluckman, M. Sharma, R. Kambadur
Erratum to: Modulation of p75NTR prevents diabetes- and proNGF-induced retinal inflammation and blood–retina barrier breakdown in mice and rats
Barbara A. Mysona, Mohammed M. H. Al-Gayyar, Suraporn Matragoon, Mohammed A. Abdelsaid, Mona F. El-Azab, H. Uri Saragovi, Azza B. El-Remessy